Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winston Tan

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Urology|February 27, 2007
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment GroupAminah Jatoi, Patrick Burch, David Hillman, et al.
Cancers|January 27, 2021
Prognostic Value of Plasma hPG<sub>80</sub> (Circulating Progastrin) in Metastatic Renal Cell CarcinomaManish Kohli, Winston Tan, Bérengère Vire, et al.
Scientific Reports|March 4, 2017
Personalized chemotherapy selection for breast cancer using gene expression profilesKaixian Yu, Qing-Xiang Amy Sang, Pei-Yau Lung, et al.
Cancers|October 14, 2022
Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate CancerJinyong Huang, Meijun Du, Alex Soupir, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2020
Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship researchMelissa S Y Thong, Raymond J Chan, Corina van den Hurk, et al.
Clinical Genitourinary Cancer|July 30, 2013
A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancerRoberto Pili, Rui Qin, P J Flynn, et al.
Clinical Prostate Cancer|October 4, 2005
A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancerElisabeth I Heath, Melvin Gaskins, Henry C Pitot, et al.
The Journal of Biological Chemistry|February 4, 2026
Electromotility can be disassociated from gating charge movement in outer hair cells of conditional alpha2 spectrin knockout miceJun-Ping Bai, Micheal C Stankewich, Jie Yang, et al.
Cancers|February 11, 2021
Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate CancerArturo Araujo, Leah M Cook, Jeremy S Frieling, et al.
Cancer Research|February 13, 2023
Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate CancerCharles Blatti, Jesús de la Fuente, Huanyao Gao, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Urology|February 27, 2007
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment GroupAminah Jatoi, Patrick Burch, David Hillman, et al.
Cancers|January 27, 2021
Prognostic Value of Plasma hPG<sub>80</sub> (Circulating Progastrin) in Metastatic Renal Cell CarcinomaManish Kohli, Winston Tan, Bérengère Vire, et al.
Scientific Reports|March 4, 2017
Personalized chemotherapy selection for breast cancer using gene expression profilesKaixian Yu, Qing-Xiang Amy Sang, Pei-Yau Lung, et al.
Cancers|October 14, 2022
Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate CancerJinyong Huang, Meijun Du, Alex Soupir, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2020
Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship researchMelissa S Y Thong, Raymond J Chan, Corina van den Hurk, et al.
Clinical Genitourinary Cancer|July 30, 2013
A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancerRoberto Pili, Rui Qin, P J Flynn, et al.
Clinical Prostate Cancer|October 4, 2005
A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancerElisabeth I Heath, Melvin Gaskins, Henry C Pitot, et al.
The Journal of Biological Chemistry|February 4, 2026
Electromotility can be disassociated from gating charge movement in outer hair cells of conditional alpha2 spectrin knockout miceJun-Ping Bai, Micheal C Stankewich, Jie Yang, et al.
Cancers|February 11, 2021
Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate CancerArturo Araujo, Leah M Cook, Jeremy S Frieling, et al.
Cancer Research|February 13, 2023
Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate CancerCharles Blatti, Jesús de la Fuente, Huanyao Gao, et al.
Pageof 9